Takayuki Kobayashi
Overview
Explore the profile of Takayuki Kobayashi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
130
Citations
700
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maeda T, Ono M, Osako T, Chiba T, Baba S, Iesato A, et al.
Cancer Med
. 2025 Feb;
14(4):e70666.
PMID: 39967410
Background: Patients with triple negative breast cancer (TNBC) who have a poor response to neoadjuvant chemotherapy (NAC) have worse survival and new treatment strategies need to be developed. TNBC is...
2.
Hirata T, Uehara Y, Hakozaki T, Kobayashi T, Terashima Y, Watanabe K, et al.
JTO Clin Res Rep
. 2025 Jan;
6(1):100761.
PMID: 39758600
[This corrects the article DOI: 10.1016/j.jtocrr.2024.100659.].
3.
Kobayashi T, Ashizuka Y
Jpn J Infect Dis
. 2025 Jan;
PMID: 39756962
Ticks are vectors of tick-borne diseases (TBDs) between humans and wild vertebrates. The relationship between ticks, host vertebrates, and their pathogens should be investigated for the effective control of TBDs....
4.
Kobayashi T, Watanabe K, Hosomi Y, Yoh K, Usui K, Kishi K, et al.
Jpn J Clin Oncol
. 2024 Dec;
55(3):275-282.
PMID: 39703157
Introduction: Osimertinib-induced interstitial lung disease in untreated EGFR-mutated, advanced non-small cell lung cancer is being reported at a higher rate in Japan than elsewhere. However, data on the interstitial lung...
5.
Aoyama Y, Ozaki Y, Kizawa R, Masuda J, Kawai S, Kurata M, et al.
Breast Cancer
. 2024 Dec;
32(2):329-336.
PMID: 39644440
Background: Neoadjuvant pembrolizumab plus chemotherapy and adjuvant pembrolizumab have been established as the optimal systemic therapies for patients with early stage triple-negative breast cancer (TNBC); however, their efficacy and feasibility...
6.
Shimizu S, Nakamura M, Kawai A, Kazama T, Abe M, Enbutsu K, et al.
Opt Express
. 2024 Nov;
32(23):41350-41360.
PMID: 39573448
This paper discusses the impact of pump-phase noise in the χ-based optical parametric amplification process on the phase-conjugated idler. We show that the dispersive fiber propagation of the phase-conjugated idler...
7.
Yanagisawa A, Kim J, Naito A, Kobayashi T, Misawa T, Sakao S, et al.
Sci Rep
. 2024 Nov;
14(1):27069.
PMID: 39511196
Pulmonary hypertension (PH) is a devastating disease characterized by vascular remodeling, resulting in right ventricular failure and death. Dysregulation of energy metabolism is linked to PH pathogenesis. Trimetazidine (TMZ), a...
8.
Otsuji K, Takahashi Y, Osako T, Kobayashi T, Takano T, Saeki S, et al.
NPJ Precis Oncol
. 2024 Oct;
8(1):222.
PMID: 39363009
Metastasis is a complex process that remains poorly understood at the molecular levels. We profiled single-cell transcriptomic, genomic, and epigenomic changes associated with cancer cell progression, chemotherapy resistance, and metastasis...
9.
Kimura K, Suzuki F, Tsujiguchi H, Hara A, Miyagi S, Kannon T, et al.
J Nutr Sci
. 2024 Sep;
13:e45.
PMID: 39345245
Although the relationship between dyslipidaemia (DL) and coronary artery disease (CAD) or between trace minerals intake and CAD is well known separately, the exact nature of this relationship remains unknown....
10.
Kobayashi T, Nishimura M, Hosonaga M, Kizawa R, Kawai S, Aoyama Y, et al.
BMC Cancer
. 2024 Sep;
24(1):1156.
PMID: 39289642
Background: Absolute lymphocyte count (ALC) is a predictive and prognostic factor for various tumor types, including breast cancer. Palbociclib is a CDK4/6 inhibitor widely used for the treatment of metastatic...